Incidence and factors related to SARS-CoV-2 infection in a cohort of patients with rheumatoid arthritis from a health service provider in Colombia during the COVID-19 pandemic.
Luis Fernando Valladales-RestrepoManuel Enrique Machado-DuqueAndrés Gaviria-MendozaHarrison David Ospina-ArzuagaMaritza Ruiz-ZapataJorge Enrique Machado-AlbaPublished in: Therapeutic advances in infectious disease (2022)
The incidence of COVID-19 is higher among patients with RA who receive DMARDs and glucocorticoids simultaneously or who have diabetes mellitus than among patients with RA not receiving these drug combinations, which should guide treatment strategies.